Scientists identify an existing drug that could aid in therapy for brain swelling
November 23, 2016Medical Communications, Research and Development University of Arkansas, concussion, head injury
A team of biomedical engineering researches, who performed their study at the University of Arkansas, have identified a drug that …
University of Toronto develops circulating tumour cell monitoring tool
November 22, 2016Research and Development University of Toronto, circulating cancer cells
Researchers at the University of Toronto have developed a new tool which promises to enable the monitoring and profiling of …
Thomas Willemson promoted to China Area Head at GSK
November 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
GlaxoSmithKline appointed a new area head in Thomas Willemsen to take charge of its China drug business. He succeeds Herve …
J&J and Genmab’s drug races to second line treatment approval
November 22, 2016Manufacturing and Production, Research and Development, Sales and Marketing Genmab, Janssen, Johnson & Johnson, darzalex, multiple myeloma
Janssen, a part of Johnson & Johnson, and Genmab have announced that their multiple myeloma drug Darzalex (daratumumab) has been …
Mylan ducks call to testify in front of Senate
November 22, 2016Manufacturing and Production, Medical Communications Department of Justice, Mylan, epipen
Mylan has avoided the call to testify in front of the Senate judiciary committee. The hearing will be convened under …
Sanofi and Novo to face off in diabetes sphere following FDA approvals
November 22, 2016Manufacturing and Production, Sales and Marketing FDA, Novo Nordisk, Sanofi, Soliqua, Xultophy, diabetes
Sanofi and Novo are set to face off in the diabetes market after the FDA approved combination treatments from the …
AstraZeneca allowed to recruit for drug trial again
November 22, 2016Manufacturing and Production, Research and Development AstraZeneca, FDA, clinical trial
AstraZeneca’s clinical trial for head and neck cancer had previously been put on partial hold by the FDA due to …
Theresa May promises £2 billion a year in funding for R&D
November 21, 2016Manufacturing and Production, Medical Communications Conservative, Theresa May, brexit
The Conservative Party leader has announced a planned raise in funding for research and development for UK business to £2 …
Acorda forced to stop development of drug
November 21, 2016Manufacturing and Production, Research and Development Acorda therapeutics, clinical trial, post-stroke
Acorda Therapeutics announced that they were unable to continue development of the drug, dalfampridine, due to lack of efficacy in …
Pfizer sues Texas agency over leak of drug prices
November 21, 2016Medical Communications, Sales and Marketing Drug pricing, Pfizer, US, texas
Pfizer has sued Texas’ Health and Human Services Commission, after it claimed the agency violated state and federal law by …
China conducts first gene-editing human trial
November 21, 2016Research and Development, Sales and Marketing China, DNA, cas9, crispr
China has used Crispr/Cas9 gene-editing technology to edit the DNA of a human subject, suffering from metastatic lung cancer. This …
GSK 18 months ahead of the game with three-drug inhaler
November 21, 2016Medical Communications, Sales and Marketing GSK, Innoviva, chronic obstructive pulmonary disease
GlaxoSmithKline, alongside its partner Innoviva, have filed a regulatory submission with the FDA for its treatment for chronic obstructive pulmonary …
Teva’s drug to replace chemotherapy in acute leukaemia
November 21, 2016Medical Communications, Sales and Marketing Teva, chemotherapy, first line, first-line, leukaemia
Teva Pharmaceutical announced that their drug Trisenox has been given approval from the European Commission to become the first line …
Novartis in $665 million deal for Selexys
November 21, 2016Sales and Marketing Novartis, SelG1, selexys
Novartis have confirmed the acquisition of Selexys Pharmaceuticals, after Selexys received positive results from a Phase II trial. Novartis had …
Top Ten most popular articles on Pharmafile.com this week
November 18, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Crohn's, Janssen, otezla, top ten
While the world is still reeling from the US presidential election results; it’s business as usual for the pharma industry; …
GSK/J&J release how their drug measures up against Humira
November 18, 2016Medical Communications, Research and Development GSK, Humira, Janssen, Johnson & Johnson, sirukumab
GlaxoSmithKline and Janssen, part of Johnson & Johnson, released the results of their two Phase III trials exploring treatment options …
Former Valeant executive and Philidor CEO charged with fraud
November 18, 2016Medical Communications, Sales and Marketing Philidor, Valeant, Valeant Pharmaceuticals, fraud
Gary Tanner, former executive, and Andrew Davenport, ex-CEO of Philidor, have been arrested and charged with fraud. Preet Bharara, US …
NICE thumbs up for BMS leukaemia treatment
November 18, 2016Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, NICE, Sprycel, chronic myeloid leukaemia
Bristol-Myers Squibb has announced that NICE have given a Final Appraisal Determination recommending Sprycel (dasatinib) for the treatment of chronic …
New healthcare app aims to improve patient adherence
November 17, 2016Medical Communications, Sales and Marketing Echo, app, patient adherence, smartphone
The newly released app, named Echo, was developed by former Apple executive Dr Sai Lakshmi and former LloydsPharmacy executive Stephen …
Japan to slash Opdivo costs by 50%
November 17, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, opdivo
Japan’s health ministry has announced it is to slash the price of Bristol-Myers Squibb’s Opdivo by 50% in the country …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
